Advertisement Averion names executive vice president of global business development - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Averion names executive vice president of global business development

Averion International, a clinical research organization, has appointed Peter Gonze as executive vice president of global business development. He will oversee Averion's global business development and marketing activities, and will serve on the company's executive management team.

For the past six years Mr Gonze was the COO at Unither Pharmacueticals. He has broad experience in all aspects of commercial operations having held senior level positions in business development, commercial operations and general management with pharmaceutical and biotech companies including: GlaxoSmithKline, RhonePoulenc Rorer (now SanofiAventis), Johnson & Johnson, Abbott Diagnostics-Medisense, and AltaRex.

Markus Weissbach, CEO of Averion International, said: “Peter brings the necessary sales, marketing and operational management experience to grow Averion’s global sales. We will continue to pursue new business opportunities in North America and Europe, and plan to expand our geographic and therapeutic capabilities in emerging regions of the world.”